Severe Dry Eye Disease
Therapeutic Neurostimulation Updates for Dry Eye Disease: Rapid Response From Chicago
This activity is supported by an educational grant from Alcon Vision, LLC.
Dry Eye Defense: The Role of Nutraceuticals
This activity is supported by an educational grant from Bausch + Lomb.
MedEd Talks: Ocular Surface and Lid Health Collaborative Care
This activity is supported by educational grants from Tarsus Pharmaceuticals, Inc. and Viatris, Inc.
Ace The Case: A 67-Year-Old Woman With Blurred Vision
This activity is supported by an educational grant from Dompé US, Inc.
Nutraceuticals for Dry Eye: Dispelling the Dogma and Embracing the Data
This activity is supported by an educational grant from Bausch + Lomb.
Richard L. Lindstrom, MD, appointed founder, chairman of Surface Ophthalmics
Healio | OSN Chief Medical Editor Richard L. Lindstrom, MD, a leader in corneal, cataract, refractive and laser surgery, has been appointed as founder and chairman of Surface Ophthalmics, according to a press release.
Dry Eye Disease and Meibomian Gland Dysfunction: Imperfect Together
This activity is supported by an educational grant from Bausch + Lomb.
First patient visit complete in phase 2b RELIEF trial of licaminlimab for dry eye disease
Oculis has announced the first patient first visit in its phase 2b RELIEF trial evaluating licaminlimab, the company’s novel anti-tumor necrosis factor-alpha biologic eye drop, for treatment of moderate to severe dry eye disease.
VIDEO: Cryopreserved amniotic membrane treats dry eye as early as 2 days after application
NEW ORLEANS — A single application of cryopreserved amniotic membrane effectively treated signs and symptoms of moderate to severe dry eye disease after just 2 days, according to Damon Dierker, OD, FAAO, at Academy ’23.
Eyeing the Options for Treating Meibomian Gland Dysfunction and Dry Eye Disease
This activity is supported by an educational grant from Bausch + Lomb.